株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

デジタルヘルス:糖尿病向けアプリと仮想コーチング

Digital Health: Diabetes Apps and Virtual Coaching

発行 Datamonitor Healthcare 商品コード 930636
出版日 ページ情報 英文 68 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=108.54円で換算しております。
デジタルヘルス:糖尿病向けアプリと仮想コーチング Digital Health: Diabetes Apps and Virtual Coaching
出版日: 2020年03月10日 ページ情報: 英文 68 Pages
概要

今後10年間にスマートフォン対応型のデジタルヘルス技術を活用して、糖尿病を改善できる可能性が生じ、それが糖尿病管理市場を一変させ、医療費の削減にもつながる、との期待が生まれつつあります。

当レポートでは、糖尿病管理のためのデジタルヘルスの市場について分析し、糖尿病の主な管理手段や目標指標、主なソリューションの内訳と特徴 - 糖尿病管理アプリ、仮想コーチング、血統モニタリング装置など -、主要企業・製品の一覧、今後の市場規模の動向見通し、将来的な技術開発・市場成長の可能性、といった情報を取りまとめてお届けいたします。

目次

エグゼクティブサマリー

第1章 糖尿病の概要

  • 1型糖尿病
  • 2型糖尿病
  • 糖尿病の有病率:今後25年間で50%増加
  • 合併症:厳格な血糖コントロールによる合併症の予防
  • 予防
  • 参考文献

第2章 血糖コントロールを達成するための新たなガイドライン

  • Ac1 - ADAの目標値:糖尿病関連の医療基準 (2019年)
  • 血糖の自己監視の重要性
  • DCCTの研究
  • 血糖管理目標のための、ADAの新規ガイドライン:範囲内
  • MedtronicのTIRの目標
  • 参考文献

第3章 血糖モニタリングと、スマートフォン主導の糖尿病アプリの登場

  • Ascensia
  • DarioHealth
  • LifeScan
  • Welldoc's BlueStar for diabetes
  • Glooko
  • mySugr
  • 参考文献

第4章 仮想糖尿病コーチング

  • Lark Technologies
  • Livongo
  • Onduo
  • One Drop
  • Virta Health Lark Technologies
  • 参考文献

第5章 革新的な持続血統モニタリング装置

  • Abbott
  • Dexcom
  • Medtronic
  • Nemaura Medical
  • Senseonics
  • 参考文献

第6章 臨床データ:デジタルヘルスは糖尿病の改善に役立つか?

  • HbA1cの有意な減少
  • 糖尿病アプリ/デジタルヘルステクノロジーの臨床研究
  • 新たに誕生した、フルサービス型の仮想糖尿病クリニック
  • 参考文献

付録A:会社リスト

目次
Product Code: #MDT20003

Overview:

This special technology-based report provides an overview of diabetes, wearable glucose monitoring devices,*smartphone-based digital health technologies, and attempts to answer the question:**can digital health help improve diabetes?

Smartphone-based digital health technologies are expected to transform the diabetes management market over the next decade by substantially improving diabetes outcomes and reducing healthcare costs.*These technologies are engaging and empowering patients, improving glycemic control, and lowering complications.*Digital health technologies are defined in this report as: diabetes smartphone apps integrated with blood glucose monitoring devices (both standard blood glucose meters and continuous glucose monitoring systems) and personalized "virtual diabetes coaching" services.

The adoption of smartphone-based digital health technologies for diabetes management is being driven by:

  • the large and growing prevalence of diabetes
  • heavy patient burden and treatment complexity
  • poorly controlled diabetes
  • spiraling diabetes-related healthcare costs
  • the rise in global smartphone usage and increased accessibility to smartphone-based "telehealth"
  • positive clinical data supporting reduced complications and healthcare costs.

Companies discussed in this report: Abbott, Ascensia Diabetes Care, Dario Health, Dexcom, Glooko, IBM Watson Health, Insulet Corporation, Lark Technologies, LifeScan, Livongo Health, Medtronic, mySugr, Nemaura Medical, Omada Health, Onduo, One Drop, Roche, Sanofi, Senseonics, Tandem Diabetes Care, Virta Health, and Welldoc.

Table of Contents

Executive Summary

  • i. Digital health is transforming diabetes management
  • ii. Benefits
  • iii. Clinical data
  • iv. Limitations
  • v. Security concerns
  • vi. Conclusion
  • vii. Bibliography

1. Diabetes Overview

  • 1.1. Type 1 diabetes: 5% of the diabetes population are insulin dependent
  • 1.2. Type 2 diabetes: 95% of the diabetes population
  • 1.3. Diabetes prevalence: rising by 50% over next 25 years
  • 1.4. Complications: tight glycemic control can prevent complications
  • 1.5. Prevention
  • 1.6. Bibliography

2. New Guidelines for Achieving Glycemic Control

  • 2.1. ADA's target A1c: 2019 Standards of Medical Care in Diabetes
  • 2.2. The importance of self-monitoring of blood glucose
  • 2.3. The DCCT study
  • 2.4. New 2019 ADA guidelines for glycemic targets: time-in-range
  • 2.5. Medtronic's TIR goals
  • 2.6. Bibliography

3. Blood Glucose Monitoring and the Rise of Smartphone-Driven Diabetes Apps

  • 3.1. Ascensia
  • 3.2. DarioHealth
  • 3.3. LifeScan
  • 3.4. Welldoc's BlueStar for diabetes
  • 3.5. Glooko
  • 3.6. mySugr
  • 3.7. Bibliography
  • Exhibit 3-1: Selected standard blood glucose meters and diabetes apps
  • Exhibit 3-2: OneTouch Verio Flex and OneTouch Reveal app
  • Exhibit 3-3: OneTouch Reveal Plus powered by Welldoc's BlueStar technology
  • Exhibit 3-4: Welldoc's BlueStar AI-driven smart diabetes app
  • Exhibit 3-5: Glooko Mobile app
  • Exhibit 3-6: mySugr app

4. Virtual Diabetes Coaching

  • 4.1. Lark Technologies
  • 4.2. Livongo
  • 4.3. Onduo
  • 4.4. One Drop
  • 4.5. Virta Health
  • 4.6. Bibliography
  • Exhibit 4-1: Onduo for diabetes
  • Exhibit 4-2: The One Drop digital diabetes management portfolio
  • Exhibit 4-3: Virta app

5. Revolutionary Continuous Glucose Monitoring Systems

  • 5.1. Abbott
  • 5.2. Dexcom
  • 5.3. Medtronic
  • 5.4. Nemaura Medical
  • 5.5. Senseonics
  • 5.6. Bibliography
  • Exhibit 5-1: Selected continuous glucose monitoring systems with diabetes apps
  • Exhibit 5-2: The FreeStyle Libre CGM 14-day sensor and LibreLink app
  • Exhibit 5-3: The Dexcom G6 CGM System with extended 10-day sensor
  • Exhibit 5-4: Dexcom CLARITY diabetes management software
  • Exhibit 5-5: The Guardian Connect CGM System with Sugar.IQ app
  • Exhibit 5-6: The SugarBEAT system
  • Exhibit 5-7: The Eversense CGM and mobile app

6. Clinical data - Can Digital Health Help Improve Diabetes?

  • 6.1. Meaningful Reduction in HbA1c
  • 6.2. Clinical review of diabetes apps/digital health technologies
  • 6.3. Emerging full-service virtual diabetes clinics
  • 6.4. Bibliography
  • Exhibit 6-1: Selected studies, average reduction in HbA1c with use of diabetes apps and/ or digital app-based coaching programs

Appendix A: company listing